FDA inspection

BCM Co., Ltd.: FDA inspection ending Sep 18, 2025

FDA inspection 1282002 · Voluntary Action Indicated (VAI) · Goyang

Key facts

Inspection ID 1282002
Firm BCM Co., Ltd.
FEI number 3014172183
Address 178 Deoksan-Ro, Ilsanseo District
City Goyang
Country Korea (the Republic of)
Fiscal year 2025
Inspection end date Sep 18, 2025
Classification Voluntary Action Indicated (VAI)
Project area Postmarket Assurance: Devices
Product type Devices

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections